AIM: To evaluate the predictive value of tissue transglutaminase (tTG) antibodies for villous atrophy in adult and pediatric populations to determine if duodenal biopsy can be avoided. METHODS: A total of 324 patients with celiac disease (CD; 97 children and 227 adults) were recruited prospectively at two tertiary centers. Human IgA class anti-tTG antibody measurement and upper gastrointestinal endoscopy were performed at diagnosis. A second biopsy was performed in 40 asymptomatic adults on a gluten-free diet (GFD) and with normal tTG levels. RESULTS: Adults showed less severe histopathology (26% vs 63%, P < 0.0001) and lower tTG antibody titers than children. Levels of tTG antibody correlated with Marsh type in both populations (r = 0.661, P < 0.0001). Multiple logistic regression revealed that only tTG antibody was an independent predictor for Marsh type 3 lesions, but clinical presentation type and age were not. A cut-off point of 30 U tTG antibody yielded the highest area under the receiver operating characteristic curve (0.854). Based on the predictive value of this cut-off point, up to 95% of children and 53% of adults would be correctly diagnosed without biopsy. Despite GFDs and decreased tTG antibody levels, 25% of the adults did not recover from villous atrophy during the second year after diagnosis. CONCLUSION: Strongly positive tTG antibody titers might be sufficient for CD diagnosis in children. However, duodenal biopsy cannot be avoided in adults because disease presentation and monitoring are different.
AIM: To evaluate the predictive value of tissue transglutaminase (tTG) antibodies for villous atrophy in adult and pediatric populations to determine if duodenal biopsy can be avoided. METHODS: A total of 324 patients with celiac disease (CD; 97 children and 227 adults) were recruited prospectively at two tertiary centers. Human IgA class anti-tTG antibody measurement and upper gastrointestinal endoscopy were performed at diagnosis. A second biopsy was performed in 40 asymptomatic adults on a gluten-free diet (GFD) and with normal tTG levels. RESULTS: Adults showed less severe histopathology (26% vs 63%, P < 0.0001) and lower tTG antibody titers than children. Levels of tTG antibody correlated with Marsh type in both populations (r = 0.661, P < 0.0001). Multiple logistic regression revealed that only tTG antibody was an independent predictor for Marsh type 3 lesions, but clinical presentation type and age were not. A cut-off point of 30 U tTG antibody yielded the highest area under the receiver operating characteristic curve (0.854). Based on the predictive value of this cut-off point, up to 95% of children and 53% of adults would be correctly diagnosed without biopsy. Despite GFDs and decreased tTG antibody levels, 25% of the adults did not recover from villous atrophy during the second year after diagnosis. CONCLUSION: Strongly positive tTG antibody titers might be sufficient for CD diagnosis in children. However, duodenal biopsy cannot be avoided in adults because disease presentation and monitoring are different.
Authors: Ivor D Hill; Martha H Dirks; Gregory S Liptak; Richard B Colletti; Alessio Fasano; Stefano Guandalini; Edward J Hoffenberg; Karoly Horvath; Joseph A Murray; Mitchell Pivor; Ernest G Seidman Journal: J Pediatr Gastroenterol Nutr Date: 2005-01 Impact factor: 2.839
Authors: K Kaukinen; M Peräaho; K Lindfors; J Partanen; N Woolley; P Pikkarainen; A-L Karvonen; T Laasanen; H Sievänen; M Mäki; P Collin Journal: Aliment Pharmacol Ther Date: 2007-05-15 Impact factor: 8.171
Authors: Matthew R Donaldson; Linda S Book; Kristin M Leiferman; John J Zone; Susan L Neuhausen Journal: J Clin Gastroenterol Date: 2008-03 Impact factor: 3.062
Authors: Matthew R Donaldson; Sean D Firth; Holly Wimpee; Kristin M Leiferman; John J Zone; Wyatt Horsley; Molly A O'Gorman; W Daniel Jackson; Susan L Neuhausen; Christopher M Hull; Linda S Book Journal: Clin Gastroenterol Hepatol Date: 2007-04-11 Impact factor: 11.382
Authors: Lincoln Hernandez; Timothy C Johnson; Afzal J Naiyer; Debby Kryszak; Edward J Ciaccio; Albert Min; Henry C Bodenheimer; Robert S Brown; Allesio Fasano; Peter H Green Journal: Dig Dis Sci Date: 2007-06-05 Impact factor: 3.199
Authors: Marcis Leja; Zakera Shums; Liene Nikitina-Zake; Mikus Gavars; Ilze Kikuste; Jay Milo; Ilva Daugule; Jelena Pahomova; Valdis Pirags; Vilnis Dzerve; Janis Klovins; Andrejs Erglis; Gary L Norman Journal: United European Gastroenterol J Date: 2015-04 Impact factor: 4.623
Authors: Marco Di Tola; Mariacatia Marino; Simone Goetze; Rossella Casale; Sara Di Nardi; Raffaele Borghini; Giuseppe Donato; Antonio Tiberti; Antonio Picarelli Journal: J Gastroenterol Date: 2016-02-29 Impact factor: 7.527
Authors: L Beltran; M Koenig; W Egner; M Howard; A Butt; M R Austin; D Patel; R R Sanderson; S Goubet; F Saleh; J Lavender; E Stainer; M D Tarzi Journal: Clin Exp Immunol Date: 2014-05 Impact factor: 4.330